Abiopharma

🔍 Buckley Jeffrey (Executive)

Company: Palantir Technologies Inc. (PLTR)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Sold 58 shares of Class A Common Stock at $172.6542 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 60,168.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 100 shares of Class A Common Stock at $173.7864 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 60,068.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 1,565 shares of Class A Common Stock at $174.8455 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,503.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 325 shares of Class A Common Stock at $175.4185 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,178.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 7 shares of Class A Common Stock at $176.3133 per share (Direct)
  Date: 2026-08-20 | Code: S | equity_swap_involved: 0 | shares_owned_after: 58,171.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,250 shares of Class A Common Stock at $174.29 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 56,921.00 | transaction_form_type: 4 | Footnotes: F7

Footnotes:

• F1: This transaction represents an automatic sale of shares to cover required tax withholding obligations in connection with the vesting of restricted stock units. All sales were conducted in compliance with the Reporting Person's Rule 10b5-1 trading plan.
• F2: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $172.19 to $173.13. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (6) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F3: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $173.21 to $174.20. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (6) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F4: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $174.21 to $175.208. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (6) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F5: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $175.21 to $176.19. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (6) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F6: This transaction represents sales executed in multiple open market sales. The sales reflected in this line item were made at prices ranging from $176.28 to $176.37. The price reported above reflects the weighted average sale price of trades occurring within that price range. See footnotes (2) through (6) for sales executed in price ranges on the date indicated. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
• F7: The Reporting Person sold shares of Class A Common Stock in the open market pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), entered into on March 12, 2026.
• REMARKS: Officer title: Chief Accounting Officer. This Form 4 has been compiled based on applicable requirements to reflect the specific transactions described herein and is not intended to disclose or describe all shares and/or other equity securities owned or beneficially held by the Reporting Person.